Site Map

IgA nephropathy

Nephropathy - IgA; Berger disease

IgA nephropathy is a kidney disorder in which antibodies (called IgA) build up in kidney tissue. Nephropathy is damage, disease, or other problems with the kidney.

IgA nephropathy is also called Berger disease.

Images

Kidney anatomy

I Would Like to Learn About:

Causes

IgA is a protein, called an antibody, that helps the body fight infections. IgA nephropathy occurs when too much of this protein is deposited in the kidneys. IgA builds up inside the small blood vessels of the kidney. Structures in the kidney called glomeruli become inflamed and damaged.

The disorder can appear suddenly (acute), or get worse slowly over many years (chronic glomerulonephritis).

Risk factors include:

IgA nephropathy can occur in people of all ages, but it most often affects males in their teens to late 30s.

Symptoms

There may be no symptoms for many years.

When there are symptoms, they may include:

Exams and Tests

IgA nephropathy is most often discovered when a person with no other symptoms of kidney problems has one or more episodes of dark or bloody urine.

There are no specific changes seen during a physical examination. Sometimes, the blood pressure may be high or there may be swelling in parts of the body.

Tests include:

Treatment

The goal of treatment is to relieve symptoms and prevent or delay chronic renal failure.

The treatment may include:

Salt and fluid intakes may be restricted to control swelling. A low-to-moderate protein diet may be recommended in some cases.

Eventually, many people must be treated for chronic kidney disease and may need dialysis.

Outlook (Prognosis)

IgA nephropathy gets worse slowly. In many cases, it does not get worse at all. Your condition is more likely to get worse if you have:

When to Contact a Medical Professional

Contact your health care provider if you have bloody urine or if you are producing less urine than usual.

Related Information

Urine - bloody
Antibody
Acute
Acute nephritic syndrome
Nephrotic syndrome
Purpura
Hypersensitivity vasculitis
Chronic kidney disease
End-stage kidney disease

References

Floege J, Barratt J, Zhang H. Immunoglobulin A nephropathy and IgA vasculitis (Henoch-Schönlein purpura). In: Johnson RJ, Floege J, Tonelli M, eds. Comprehensive Clinical Nephrology. 7th ed. Philadelphia, PA: Elsevier; 2024:chap 24.

Saha MK, Pendergraft WF, Jennette JC, Falk RJ. Primary glomerular disease. In: Yu ASL, Chertow GM, Luyckx VA, Marsden PA, Skorecki K, Taal MW, eds. Brenner and Rector's The Kidney. 11th ed. Philadelphia, PA: Elsevier; 2020:chap 31.

BACK TO TOP

Review Date: 8/28/2023  

Reviewed By: Walead Latif, MD, Nephrologist and Clinical Associate Professor, Rutgers Medical School, Newark, NJ. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

ADAM Quality Logo
Health Content Provider
06/01/2025

A.D.A.M., Inc. is accredited by URAC, for Health Content Provider (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics. This site complied with the HONcode standard for trustworthy health information from 1995 to 2022, after which HON (Health On the Net, a not-for-profit organization that promoted transparent and reliable health information online) was discontinued.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2024 A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

A.D.A.M. content is best viewed in IE9 or above, Firefox and Google Chrome browser.